Page last updated: 2024-09-04

ezetimibe and Headache

ezetimibe has been researched along with Headache in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bartuli, A; Bergeron, J; Bhatia, AK; Buonuomo, PS; Descamps, OS; Gaudet, D; Greber-Platzer, S; Hovingh, GK; Kastelein, JJP; Luirink, I; Mach, F; Raal, FJ; Ruzza, A; Santos, RD; Stefanutti, C; Wang, B; Wiegman, A	1
Hanson, M; Hoffman, R; Strony, J; Veltri, E	1

Trials

2 trial(s) available for ezetimibe and Headache

Article	Year
Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT. The lancet. Diabetes & endocrinology, 2022, Volume: 10, Issue:10 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Child; Cholesterol, LDL; Double-Blind Method; Ezetimibe; Headache; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Proprotein Convertase 9; Subtilisins; Treatment Outcome	2022
Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients. Clinical therapeutics, 2008, Volume: 30, Issue:12 Topics: Adult; Aged; Anticholesteremic Agents; Arthralgia; Azetidines; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Headache; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Patient Dropouts; Pravastatin; Respiratory Tract Infections; Simvastatin; Sinusitis; Treatment Outcome; Triglycerides	2008

Article

Year

Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT.

The lancet. Diabetes & endocrinology, 2022, Volume: 10, Issue:10

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Child; Cholesterol, LDL; Double-Blind Method; Ezetimibe; Headache; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Proprotein Convertase 9; Subtilisins; Treatment Outcome

2022

Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.

Clinical therapeutics, 2008, Volume: 30, Issue:12

Topics: Adult; Aged; Anticholesteremic Agents; Arthralgia; Azetidines; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Headache; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Patient Dropouts; Pravastatin; Respiratory Tract Infections; Simvastatin; Sinusitis; Treatment Outcome; Triglycerides

2008